COVID-19 and multiorgan failure: A narrative review on potential mechanisms
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in
December 2019 form Wuhan, China leads to coronavirus disease 2019 (COVID-19) …
December 2019 form Wuhan, China leads to coronavirus disease 2019 (COVID-19) …
Biomarkers in COVID-19: an up-to-date review
M Samprathi, M Jayashree - Frontiers in pediatrics, 2021 - frontiersin.org
The ongoing pandemic of coronavirus disease 2019 (COVID-19) poses several challenges
to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of …
to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of …
Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Background and aims The main causes of death in patients with severe Coronavirus
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …
Hematologic disorders associated with COVID-19: a review
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2.
Primarily an infection of the lower respiratory tract, it is now well known to cause multisystem …
Primarily an infection of the lower respiratory tract, it is now well known to cause multisystem …
Dissecting lipid metabolism alterations in SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-
19 pandemic that has infected over a hundred million people globally. There have been …
19 pandemic that has infected over a hundred million people globally. There have been …
Blood coagulation parameter abnormalities in hospitalized patients with confirmed COVID-19 in Ethiopia
S Araya, MA Mamo, YG Tsegay, A Atlaw, A Aytenew… - Plos one, 2021 - journals.plos.org
Background Coagulopathy and thromboembolic events are among the complications of
Corona Virus disease 2019 (COVID-19). Abnormal coagulation parameters in COVID-19 …
Corona Virus disease 2019 (COVID-19). Abnormal coagulation parameters in COVID-19 …
Angiotensin–Converting Enzyme (ACE) 1 Gene Polymorphism and Phenotypic Expression of COVID-19 Symptoms
N Yamamoto, N Nishida, R Yamamoto, T Gojobori… - Genes, 2021 - mdpi.com
The renin–angiotensin–aldosterone system (RAAS) appears to play an important role in
SARS-CoV-2 infection. Polymorphisms within the genes that control this enzymatic system …
SARS-CoV-2 infection. Polymorphisms within the genes that control this enzymatic system …
[HTML][HTML] Spectrum of hematological changes in COVID-19
S Gajendra - American journal of blood research, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is caused by pathogenic and highly
transmissible Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is a …
transmissible Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is a …
Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review
AM Sun, T Hoffman, BQ Luu, N Ashammakhi… - Bio-design and …, 2021 - Springer
There is a pressing need for effective therapeutics for coronavirus disease 2019 (COVID-
19), the respiratory disease caused by severe acute respiratory syndrome coronavirus 2 …
19), the respiratory disease caused by severe acute respiratory syndrome coronavirus 2 …
Topical hemostatic materials for coagulopathy
Medical science has witnessed significant progress in the development of hemostatic
materials, which save lives by supporting natural hemostatic ability. However, for the …
materials, which save lives by supporting natural hemostatic ability. However, for the …